ABOS Insider Trading Activity and SEC Form 4 Filings
ABOS insider trading summary
Over the past 12 months, insiders at Acumen Pharmaceuticals, Inc. (ABOS) reported 45 sales worth $608K by 7 insiders and no open-market purchases on SEC Form 4. Net insider selling was $608K.
Latest ABOS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Derrell Porter | Director | Sell | $30K (13,040 @ $2.33) |
| Jun 16, 2026 | Derrell Porter | Director | Sell | $30K (12,800 @ $2.33) |
| Jun 15, 2026 | Derrell Porter | Director | Sell | $15K (6,460 @ $2.35) |
| Jun 9, 2026 | Nathan B Fountain | Director | Sell | $14K (6,400 @ $2.23) |
| Mar 6, 2026 | Derek M Meisner | Chief Legal Officer & Corp Sec | Sell | $7K (2,090 @ $3.26) |
| Feb 27, 2026 | Derek M Meisner | Chief Legal Officer & Corp Sec | Sell | $28K (9,406 @ $3.01) |
| Jan 28, 2026 | Derek M Meisner | Chief Legal Officer & Corp Sec | Sell | $8K (2,671 @ $3.00) |
| Jan 26, 2026 | Derek M Meisner | Chief Legal Officer & Corp Sec | Sell | $45K (15,085 @ $3.00) |
| Jan 23, 2026 | Derek M Meisner | Chief Legal Officer & Corp Sec | Sell | $11K (5,633 @ $1.90) |
| Jan 22, 2026 | Russell Barton | Chief Operating Officer | Sell | $850 (462 @ $1.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.